WellCell Holdings Co., Limited has issued its proxy form and meeting notice for the annual general meeting (AGM) set for 11:00 a.m. on 27 May 2026 at the Meeting Room, 4th Floor, Building 8, Xiangzhou Chuanggang Centre, Zhuhai City, Guangdong Province, PRC.

Key resolutions to be tabled include:

1. Financial Statements • Shareholders will consider and adopt the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and independent auditor’s reports.

2. Board Composition and Remuneration • Re-election of two executive directors (Mr. Jia Zhengyi and Mr. Zhang Xiaolong), one non-executive director (Mr. Lin Qihao) and one independent non-executive director (Mr. Chan Wai Dune). • Authorisation for the board to determine directors’ remuneration.

3. Auditor Re-appointment • Ascenda Cachet CPA Limited is nominated for re-appointment as external auditor, with the board empowered to fix its fees.

4. Share Capital Authorities • General mandate permitting directors to allot and issue shares of up to 20 % of the company’s issued share capital. • Separate mandate allowing repurchase of up to 10 % of issued shares. • Extension of the issuance mandate by the number of shares repurchased under the buy-back mandate.

Proxy Logistics • Completed proxy forms must reach Boardroom Share Registrars (HK) Limited no later than 48 hours before the AGM. • Shareholders entitled to attend, speak and vote may appoint proxies; a proxy need not be a shareholder.

The notice of meeting, dated 24 April 2026, outlines full procedural details and shareholder rights in connection with the AGM.